PeptiVir
Aurora
About PeptiVir
PeptiVir, Inc., a biopharmaceutical company, engages in the development and commercialization of synthetic peptide-based vaccines for the prevention of viral diseases. Its products include PVI-1000, an influenza vaccine for protection against various seasonal and pandemic strains. PeptiVir, Inc. was incorporated in 2010 and is based in Aurora, Colorado.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $300.0K
- Funding stage: Seed
- Last round: Seed (Nov 2010)
- Website: site.peptivir.com
- Phone: 7208594044
Industries & Categories
Biopharma, Biotechnology, Developer Platform
Canonical: https://fsome.com/organization/peptivir-2980127 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.